Skip to main content

MARSHALL WACE, LLP

Position in ILMN — Illumina, Inc.

CIK 1318757 LONDON, X0

Position in ILMN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,981,078
-$44,186,705 QoQ
Shares Held
102,264
-79.7% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#142
of 932 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ILMN Over Time

Shares Held

Position Value (USD)

Derivatives in ILMN

reported options exposure · as of Mar 31, 2026
CallValue
$12,326
CallShares
100
PutValue
$49,304
PutShares
400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $872,920,182 across 27 Diagnostics & Research names. ILMN ranks #12 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ILMN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,981,078 102,264
2026-03-31 $62,167,783 504,363
2026-03-31 $49,304 400
2026-03-31 $12,326 100
2025-12-31 $19,212,054 146,478
2025-12-31 $131,160 1,000
2025-12-31 $13,116 100
2025-06-30 $5,690,729 59,645
2025-03-31 $3,175,742 40,027
2024-09-30 $161,677,492 1,239,763
2024-06-30 $77,627,719 743,703
2023-12-31 $20,610,726 148,023
2022-12-31 $8,783,365 43,439
2022-09-30 $9,990,146 52,362
2022-06-30 $121,444,369 658,735
2022-03-31 $17,854,690 51,101
2021-12-31 $69,867,420 183,649
2021-09-30 $55,772,192 137,502
2021-06-30 $14,631,179 30,919
2021-03-31 $15,482,225 40,312
2020-09-30 $32,564,671 105,360